Newly christened AccelaRAD unveiled at HIMSS 2009 a service that allows patients unprecedented control over their medical images. The service, called SeeMyRadiology.com, is designed to provide patients the opportunity to create personalized libraries of images in a centralized location. Using this service, patients own their digital medical images, choosing which ones to easily and securely share with whom, particularly physicians.
Newly christened AccelaRAD unveiled at HIMSS 2009 a service that allows patients unprecedented control over their medical images. The service, called SeeMyRadiology.com, is designed to provide patients the opportunity to create personalized libraries of images in a centralized location. Using this service, patients own their digital medical images, choosing which ones to easily and securely share with whom, particularly physicians.
The service can also be used by physicians to send medical images to other facilities. All they need do is log onto the URL, upload images, then advise physicians at the facility where they are referring their patients that the images are available for downloading.
SeeMyRadiology.com can be branded with an imaging site’s name to enhance recognition, according to AccelaRAD, formerly known as Neurostar, which is framing the application as a major step toward realizing the benefits of comprehensive electronic medical records (EMRs). Developed in collaboration with The Ohio State University Medical Center in Columbus and Piedmont Hospital in Atlanta, SeeMyRadiology.com includes a toolkit enabling seamless standards-based image integration with a full range of PACS, EMRs and personal health records systems.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.